Showing results (141-150 of 183) with videos related to
Sort By:
Pageof 19
Arthritis Care & Research|July 24, 2015
Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational RegistriesSuzanne M M Verstappen, Johan Askling, Niklas Berglind, et al.Annals of the Rheumatic Diseases|December 2, 2015
How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registriesJohan Askling, Niklas Berglind, Stefan Franzen, et al.Annals of the Rheumatic Diseases|February 10, 2016
Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular diseaseKaleb Michaud, Niklas Berglind, Stefan Franzén, et al.RMD Open|October 31, 2017
Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programmeHisashi Yamanaka, Johan Askling, Niklas Berglind, et al.ERJ Open Research|February 7, 2019
Prospective observational study in patients with obstructive lung disease: NOVELTY designHelen K Reddel, Maria Gerhardsson de Verdier, Alvar Agustí, et al.JAMIA Open|November 29, 2023
Evaluating the impact of alternative phenotype definitions on incidence rates across a global data networkRupa Makadia, Azza Shoaibi, Gowtham A Rao, et al.Clinical Rheumatology|April 27, 2018
Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional studyDimitrios A Pappas, Fredrik Nyberg, Joel M Kremer, et al.Wellcome Open Research|February 28, 2023
Characteristics and outcomes of COVID-19 patients with COPD from the United States, South Korea, and EuropeDavid Moreno-Martos, Katia Verhamme, Anna Ostropolets, et al.Journal of Proteome Research|July 20, 2007
Personalized medicine and proteomics: lessons from non-small cell lung cancerGyörgy Marko-Varga, Atsushi Ogiwara, Toshihide Nishimura, et al.Plos One|July 30, 2011
Proteomic biomarkers for acute interstitial lung disease in gefitinib-treated Japanese lung cancer patientsFredrik Nyberg, Atsushi Ogiwara, Chris G Harbron, et al.Pageof 19